During the past decade, Fairfax Northern VA Hem-Onc PC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fairfax Northern VA Hem-Onc PC" #1 sponsor was "US Oncology Research" with 5 trials, followed by "Eisai Inc." with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "SCRI Development Innovations, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fairfax Northern VA Hem-Onc PC" #1 collaborator was "Sanofi" with 2 trials as a collaborator, "Chiron Corporation" with 1 trials as a collaborator, "Eisai Limited" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Fred Hutchinson Cancer Center" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Fairfax Northern VA Hem-Onc PC" are "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (2 trials), "Androgen-independent Prostate Cancer" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Fairfax Northern VA Hem-Onc PC" in a lesser frequency.

Most popular intervention types in "Fairfax Northern VA Hem-Onc PC" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adjuvant endocrine therapy" (1 trials), "Aldesleukin" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fairfax Northern VA Hem-Onc PC" are 4 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fairfax Northern VA Hem-Onc PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fairfax Northern VA Hem-Onc PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fairfax Northern VA Hem-Onc PC, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".